Press Releases

• Cyxone files regulatory submission to start clinical phase 2b study with Rabeximod

  23 Jun, 2022 12:23 CEST

• Tara Heitner steps down as CEO of Cyxone

  20 Jun, 2022 16:25 CEST
  Regulatory
  MAR

• First Berlin Equity Research publishes independent analysis of Cyxone

  17 May, 2022 15:36 CEST

• Bulletin from the annual general meeting in Cyxone AB on 16 May 2022

  16 May, 2022 11:00 CEST
  Regulatory

• Adjusted proposal regarding election and remuneration of board members prior to the Annual General Meeting of Cyxone AB

  12 May, 2022 16:55 CEST
  Regulatory